Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Response Biomedical Corp. to Present at Upcoming Investor Conference

VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/02/13 -- Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) today announced that Chief Executive Officer, Jeffrey L. Purvin will be presenting at the OneMedForum Healthcare conference to be held at the Sir Francis Drake Hotel in San Francisco on Wednesday, January 9, 2013 at 10:00 a.m. PT. A link to the webcast will be made available on the day of the presentation and for 60 days thereafter at www.responsebio.com.

About Response Biomedical Corp.

Response develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP® platform for clinical and environmental applications. RAMP® represents a unique paradigm in diagnostics that provides reliable laboratory quality results in minutes. It is ideally suited to both point of care testing and laboratory use.

The RAMP® system consists of a reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. RAMP® clinical tests are commercially available for the early detection of heart attack, congestive heart failure, Influenza A+B and RSV through our commercial partners and distributors. In the non-clinical market, RAMP® tests are currently provided for the environmental detection of West Nile Virus and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin.

Forward-Looking Statements

Certain statements contained in this news release constitute forward-looking information or forward-looking statements (collectively, "forward-looking statements") with the meaning of applicable securities legislation. Forward-looking statements are made based on assumptions made by the Company regarding various matters. Although the Company believes the expectations reflected in such forward-looking statements, and the assumptions upon which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct.

Readers are cautioned not to place undue reliance on forward-looking statements included in this news release, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements.

Many factors may cause the Company's actual results to differ materially from any forward-looking statement, including the factors detailed in the Company's filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our amended annual report on Form 10-K, our quarterly reports on Form 10-Q, our Annual Information Form and other filings with the Securities and Exchange Commission and Canadian securities regulatory authorities.

Contacts:
Response Biomedical Corp.
Patricia Massitti
VP, Administration & Corporate Communications
604-456-6010
ir@responsebio.com
www.responsebio.com

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
We spend a lot of time talking and writing about the IoT (Internet of Things) in the macro, as a giant worldwide network of objects and things, communicating with themselves and others. That is indeed interesting, but the most interesting components of the IoT, in my opinion, are the ...
For those of you using Cassandra or considering it, we’ve got another Sematext user’s Planet Cassandra case study for your reading pleasure. In this Q&A/use case, Alain Rodriguez, main Data Architect for Teads.tv, talks about the business and technical needs that drove their decision ...
This week’s post is about the trials and tribulations of companies who make wearable applications – from fitness trackers to the nascent smartwatch market. They have a tough road ahead, and the competition is heating up. And everyone is talking about them. You may be thinking: what is ...
Infrastructure and Operations Management may seem like just so many blinking lights in the back room, as parallel shadow projects are launched by department heads who can't wait on IT. Today, these shadow projects are more prevalent than ever as more non-tech managers look for easy acc...
The mantra of the day is – performance, performance, performance! It is clear that everything needs to be totally available all of the time, function at the fastest speeds and performance as close to perfect as is possible. In all the business discussions swirling around us we hear the...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE